focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,138.00
Bid: 12,134.00
Ask: 12,138.00
Change: -28.00 (-0.23%)
Spread: 4.00 (0.033%)
Open: 12,186.00
High: 12,198.00
Low: 12,114.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: UK strikes continue; AstraZeneca wins Japan approvals

Wed, 28th Dec 2022 07:40

(Alliance News) - Stocks in London are set to open higher on Wednesday as UK markets returned to business following the Christmas break.

Financial markets in France, Germany, and the US had resumed trading on Tuesday.

The CAC 40 in Paris ended 0.7% higher on Tuesday, while the DAX 40 in Frankfurt rose 0.4%. Wall Street closed mixed.

The monster storm that killed dozens in the US over the Christmas weekend continued to inflict misery on New York state and air travellers nationwide Tuesday, as stories emerged of families trapped for days during the 'blizzard of the century'.

The US is considering Covid entry restrictions for travellers from China, US officials said, after Beijing dramatically loosened hardline containment measures this month.

Infections have surged across China as key pillars of its containment policy have been dismantled, prompting US officials to express concern at the potential for new variants to be unleashed.

Here is what you need to know ahead of the London market open:

----------

MARKETS

----------

FTSE 100: called up 32.49 points, or 0.4%, at 7,505.50

----------

Hang Seng: up 1.4% at 19,874.81

Nikkei 225: closed down 0.4% at 26,340.50

S&P/ASX 200: closed down 0.3% at 7,086.40

----------

DJIA: closed up 37.63 points, 0.1%, at 33,241.56

S&P 500: closed down 0.4% at 3,829.25

Nasdaq Composite: closed down 1.4% at 10,353.23

----------

EUR: higher at USD1.0652 (USD1.0641)

GBP: higher at USD1.2045 (USD1.2027)

USD: higher at JPY133.87 (JPY133.54)

Gold: lower at USD1,809.62 per ounce (USD1,812.04)

(Brent): lower at USD84.43 a barrel (USD84.89)

(changes since previous London equities close)

----------

ECONOMICS

----------

Wednesday's key economic events still to come:

10:00 EST US Richmond Fed business activity survey

16:30 EST US API weekly statistical bulletin

08:55 EST US Johnson Redbook retail sales index

10:00 EST US pending home sales index

----------

Travel disruption is expected across railways in the UK again on Wednesday, with many commuters returning to work following the Christmas break, as industrial action by rail workers continues. Members of the Transport Salaried Staffs' Association at Great Western Railway will walk out from noon to 11.59am on Thursday, and at West Midlands Trains for 24 hours from noon until the same time on Thursday. Meanwhile, unions are looking at ways to stage further strikes by splitting ballots by job titles rather than holding a single vote, according to reports. It comes after a day of travel chaos despite a rail strike by the Rail, Maritime and Transport Workers' Union coming to an end, with crowds of people left waiting at major train stations across London and many journeys delayed due to the late handover of engineering works.

----------

The Irish taoiseach has said he is "not hung up" on the introduction of a 30% tax band to help squeezed middle earners. Leo Varadkar said he is "determined" to make policy changes to ensure people can earn up to EUR50,000 a year without having to pay the highest rate of income tax. He added that whether that comes about by increasing the standard rate cut-off point or by the introduction of a middle tax rate of 30% will have to be decided at Cabinet. Varadkar proposed the introduction of a new middle rate tax band last March as a way of helping middle income earners.

----------

US President Joe Biden departed Tuesday for the US Virgin Islands, exchanging a deadly snowstorm for a Caribbean vacation – and an expected New Year's resolution to seek re-election in 2024. He took flack from early morning Fox News hosts for being "ready to go have a good time" while Americans confront the blizzard. However, Biden headed to the island of St Croix with a successful 2022 behind him and momentum building for him to declare, at the unprecedented age of 80, that he wants another four years in the White House. Whatever gets decided in the Caribbean will initially remain a closely held secret. However, Chief of Staff Ron Klain says that the announcement is only a matter of time. "The president will make that decision, I expect, shortly after the holidays," Klain said this month. "I expect the decision will be to do it."

----------

BROKER RATING CHANGES

----------

Goldman Sachs cuts Diageo price target to 4,700 (4,800) pence - 'buy'

----------

Barclays raises Drax price target to 1,100 (1,000) pence - 'overweight'

----------

COMPANIES - FTSE 100

----------

Miner Fresnillo confirmed the final testing of the downstream power distribution and control systems at the Juanicipio project in Mexico is now complete. This concludes the additional testing requesting by Mexico's state-owned power company, CFE. As a result, Fresnillo said the entire system has now been energised, and commissioning of the project has formally begun. It added that ramp up will now be conducted "at pace", with the objective of reaching full nameplate capacity in the second quarter of 2023. "Once commissioning is concluded, ore will be processed at the Juanicipio plant and could also continue to be processed at our nearby Saucito and Fresnillo operations if required," the company said.

----------

Pharmaceutical firm AstraZeneca announced the approval of a number of treatments in Japan. It said its immunotherapies Imfinxi and Imjudo have been approved in Japan for advanced liver, biliary tract and lung cancer, while its selective Bruton's tyrosine kinase inhibitor Calquence has been approved in the country for the treatment of adults with treatment-naive chronic lymphocytic leukaemia. AstraZeneca said the approvals were based on positive clinical trials.

----------

COMPANIES - FTSE 250

----------

IMI completed its acquisition of smart thermostatic control manufacturer Heatmiser UK. The acquisition was first announced at the beginning of November for an enterprise value of GBP110 million. IMI added at the time that a further GBP8 million could be paid based on Heatmiser's future financial performance. Heatmiser will become part of IMI Hydronic. Chief Executive Roy Twite said: "With Heatmiser's expertise in connected controls, we have created a significant opportunity to accelerate our growth in smart buildings."

----------

OTHER COMPANIES

----------

Impact Healthcare REIT said it has agreed to an increase in the size of its existing revolving credit facility with Clydesdale Bank, which trades as Virgin Money. The healthcare real estate investor also agreed to an extension to the term and a reduction in the margin of the facility. The revised facility has been increased to GBP50 million from GBP25 million and extends the maturity to December 2029, from March 2024. The revised facility has an improved margin of 200 basis points over the sterling overnight index average, down from 225 basis points on the original facility. This takes the group's total debt facilities to GBP241 million from GBP216 million.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.

More News
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.